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ABSTRACT: Three familial variants of the presynaptic protein R-synuclein (RS), A30P, E46K, and A53T,
correlate with rare inherited Parkinson’s disease (PD), while wild-type RS is implicated in sporadic PD. The
classic manifestation of both familiar and sporadic PD is the formation of fibrillar structures of RS which
accumulate as the main component in intraneuronal Lewy bodies. At presynaptic termini, the partitioning of
RSbetweendisorderedcytosolicandmembrane-boundstateslikelymediatesitsproposedroleinregulationof
reserve pools of synaptic vesicles. Previously, we reported on multiple distinct phospholipid binding modes of
RS with slow binding kinetics. Here, we report the phospholipid binding properties of the disease variants,
viewed by solution NMR in a residue-specific manner. Our results agree qualitatively with previous
biophysical studies citing overall decreased lipid affinity for the A30P mutation, comparable affinity for
A53T, and an increased level of binding of E46K, relative to wild-type RS. Additionally, our NMR results
describe the distribution of lipid-bound states for RS: the population of the SL1 binding mode (residues 3-25
bound as a helix) is augmented by each of the disease variants, relative to wild-type RS. We propose that the
SL1 binding mode, which anchors the N-terminus of RS in the lipoprotein complex while the hydrophobic
NAC region remains dynamically disordered, is prone to intermolecular interactions which progress toward
disease-associated oligomers and fibrils. The elevation of the SL1 binding mode, unchecked by a propor-
tionate population of binding modes incorporating the full N-terminal domain, may well account for the
increased toxicity of the A30P, E46K, and A53T disease variants of RS.
In dopaminergic neurons, R-synuclein (RS)
1 partitions be-
tween a disordered cytosolic state and helical phospholipid-
bound forms. Membrane association of RS likely mediates its
role in regulation of reserve pools of synaptic vesicles and
dopamine homeostasis, but it is also implicated in the fibril
formation propensity (1-7) and oligomeric pathways (8-10)o f
RS, which have been widely studied for their relevance to
Parkinson’s disease (PD). Three rare autosomal dominant mis-
sense mutations of RS, A30P, E46K, and A53T, have been
discovered in European kindred with inherited early onset
Parkinson’s disease (11-13). Wild-type RSi si m p l i c a t e di nt h e
pathology of sporadic PD, which accounts for the vast majority
ofcases.Whetherfamilialorsporadic,thehistologicalexpression
of PD is the formation of fibrillar structures of RSw h i c h
accumulateasthemaincomponentinintraneuronalLewybodies
and neurites (14, 15). The rate of fibril formation in wild-type RS
is increased by the presence of dilute lipids and lipid mimetics
(1, 3-6) but decreased in the presence of high lipid concen-
trations (2-6). Among the three disease variants, aggregation
kinetics also have been determined in vitro under lipid-free
conditions (16-21) and in catecholaminergic cells with similar
results (22), but expectations that the mutant proteins would
systematically display higher aggregation propensity and faster
fibrilization rates were not borne out. Instead, A30P fibrils form
more slowly than wild-type fibrils (16-19), while the E46K and
A53T mutationsdoresultinfasterfibrillizationkinetics(16-22).
Subsequent studies focused on the formation of prefibrillar RS
oligomers, which have increasingly been hypothesized as the
relevant toxic agent in PD. A number of studies in which
preformed oligomers have been added to various membranes
have observed vesicle leakage or pore formation, suggesting that
neuron damage is the result of membrane disruption by oligo-
meric RS( 23-29). The rates of conversion among monomeric
RS, prefibrillar oligomers, and mature fibrils in the A30P and
A53T disease variants are altered from wild-type behavior in a
manner that may allow a dangerous accumulation of early
oligomeric species (30, 31). The extent of accumulation of
E46K prefibrillar species, however, is reduced relative to that
of wild-type RS( 32).
The degree of residual R-helical propensity detected in the
N-terminal domain of lipid-free RS, measured by deviations in
†This work is funded by the Intramural Research Program of the
National Institute of Diabetes and Digestive and Kidney Diseases,
National Institutes of Health (Grant DK029047 to A.B.), and by the
Leverhulme Trust and the Wellcome Trust (to C.M.D.).
*To whom correspondence should be addressed: 5 Memorial Dr.,
Bethesda,MD20892-0520.Phone:(301)496-2848.Fax:(301)402-0907.
E-mail: bax@nih.gov.
1Abbreviations: RS, R-synuclein; BMRB, BioMagResBank; DOPC,
1,2-dioleoyl-sn-glycero-3-phosphocholine; DOPE, 1,2-dioleoyl-sn-gly-
cero-3-phosphoethanolamine; DOPS, 1,2-dioleoyl-sn-glycero-3-phos-
pho-L-serine; EBURP, excitation band-selective, uniform response,
pure phase; EPR, electron paramagnetic resonance; HMQC, hetero-
nuclear multiple-quantum coherence; HSQC, heteronuclear single-
quantum coherence; LUV, large unilamellar vesicle; NAC, nonamyloid
component; NOE, nuclear Overhauser effect; NMR, nuclear magnetic
resonance; PD, Parkinson’s disease; REBURP, refocused band-selec-
tive, uniform response, pure phase; SUV, small unilamellar vesicle;
TROSY, transverse relaxation-optimized spectroscopy; WT, wild type.Article Biochemistry, Vol. 49, No. 5, 2010 863
chemical shifts from random coil values, has been used as an
indicator to study structural differences between the disease
variants (33, 34). Partitioning of each of the constructs to a
helical, bound form in the presence of lipid mimetics has also
been characterized (35-37). Here again, the simple model that
supposes that structure adopted in a membrane-bound confor-
mation of RS would be protective against aggregation is not
supported by themutantRS data.The A30Pvariantdoesdisplay
lower helical propensity and disrupted membrane interactions;
however, E46K partitions more easily to the bound state, while
the A53T mutation exhibits a lower helix propensity combined
with a membrane affinity comparable to that of the wild type
(17,19,38).Clearly,amoredetailedpictureisneededtoreconcile
the fact that none of these hypothesized indicators (fibril forma-
tionrates,oligomeraccumulation,residualhelicalconformation,
or membrane affinity) satisfactorily accounts for the potency of
the RS disease mutants.
For wild-type (WT) RS, we recently described distinct
phospholipid binding modes that exhibit slow exchange
kinetics (39). Interestingly, evidence of slow exchange kinetics
is also found in the study of interactions between fatty acids
and WT RS( 9). Though the bound modes are observed only
indirectly because the large size and/or dynamic behavior of
the lipid-bound states makes them inaccessible to solution
NMR experiments, the bound segments of the protein can be
resolved to the level of individual residues. Here we investigate
the membrane interactions of the disease variants of RSi na n
analogous manner. The results reveal for each of the variants a
redistribution of bound modes from that observed for WT RS.
The implications lead us to propose a new mechanism by which
RS is protected from or predisposed to the early events of
aggregation.
EXPERIMENTAL PROCEDURES
Protein Expression andPurification. Human wild-typeRS
with
15Na n d
2H isotopic enrichment was expressed and purified
byanion-exchangechromatographyaspreviouslydescribed(39).
A30P, E46K, and A53T RS were expressed from recombinant
plasmids produced by mutagenesis of the wild-type sequence
using Quikchange mutagenesis reagents and standard PCR
techniques. All complementary primers were synthesized by the
U.S. Federal Drug Administration (FDA). DNA sequencing
verified the presence of the desired mutations (FDA, Bethesda,
MD). The disease variants were purified in the same manner as
the WT protein. Purified protein was dialyzed into water and
lyophilized for storage.
Preparation of Lipid Vesicles. Phospholipids were pur-
chased as a lyophilized mixture (5:3:2 DOPE/DOPS/DOPC)
from Avanti Polar Lipids (Alabaster, AL) and used without
further purification. A 15% (w/v) stock solution of small
unilamellar vesicles (SUVs) was prepared as previously de-
scribed (39). More dilute solutions of SUVs were made from
the stock solution as necessary for experimental purposes. Large
unilamellar vesicles (LUVs) were prepared by multiple cycles of
extrusion using the Avanti Polar Lipids mini-extruder through
membranes with a 100 nm pore size, resulting in relatively
uniformly sized vesicles with an average diameter of 140 nm, as
judged by dynamic light scattering on a Malvern Zetasizer
(model ZEN3601) instrument.
1H NMR resonances of the
terminal alkane moieties of the fatty acid chains in LUVs exhibit
more rapid transverse relaxation and correspondingly larger line
widths than the corresponding resonances in SUVs (Figure 4 of
the Supporting Information).
NMR Spectroscopy. NMR spectra were recorded at 293 K
on a Bruker spectrometer operating at a
1H frequency of
600 MHz equipped with a cryogenic probe. Data were processed
and analyzed using NMRPipe (40). Samples were prepared from
lyophilized protein dissolved in 20 mM Na2HPO4 (pH 6.0), a
94% H2O/6% D2O mixture, and 0.02% NaN3. Concentrations
were determined by UV-visible spectra using an extinction
coefficient for RS( ε280)o f5 1 2 0M
-1 cm
-1 and were confirmed
via one-dimensional (1D) proton NMR by comparison of signal
intensity to a reference at a known concentration.
Nopriorbackboneamide
1H-
15Nassignmentsfordisordered
RS at nearly neutral pH were available in the BioMagResBank
(BMRB), and our assignments appear to differ somewhat from
those shown in several previously published, annotated spectra.
In particular for residues lying within the KTKEGV repeat
motifs of RS, chemical shift degeneracy can result in ambiguity
in assignment by conventional techniques. Therefore, extensive
sequential NOE correlations observed for RSi nt h ep r e s e n c eo f
lipids (39) were used to confirm the sequence assignments of WT
RS inour work. Onthe other hand,our
15N chemicalshift values
areinexcellentagreementwiththosereportedbyBermeletal.on
the basis of direct
13C detection experiments (41). Resonance
assignments for A30P, E46K, and A53T RSw e r em a d eb yt h e
transferoftheverysimilarwild-typeassignments.Smallchemical
shift changes were observed only for those residues in the
immediate vicinity of the mutation site, and assignments of these
residues were again verified by sequential cross-peaks in three-
dimensional (3D) HMQC-NOE-HMQC spectra, described be-
low. Complete
1H-
15N assignments (residues 3-140, excluding
proline residues) for disordered WT, A30P, E46K, and A53T RS
have been deposited in the BMRB (accession numbers 16543,
16546, 16547, and 16548, respectively) and are available as
Supporting Information.
For experiments in which lipids were titrated into the sample,
HSQC spectra were recorded with a data matrix consisting of
1280(t2,
1H) 448(t1,
15N)complexpoints(t2,max=152ms,and
t1,max=334ms).The
15NTROSYexperimentsformeasurement
of R2
T (42, 43) were conducted as interleaved experiments with
12 T2 delays (20, 30, 50, 70, 90, 120, 150, 180, 220, 270, 400, and
500 ms) and acquisition times matching those of the regular
HSQC experiments. 3D HMQC-NOE-HMQC spectra were
recorded with a mixing time of 100 ms, as data matrices
consisting of 2048 (t3,
1H)   84 (t2,
15N)   84 (t1,
15N) complex
points (t3,max = 106 ms, t2,max = 60.8 ms, and t1,max = 60.8 ms).
Amide-selective EBURP and REBURP pulses (44), of 1.8 ms
duration each and centered at 8.3 ppm, were used for both
experiments.
RESULTS
Relative Phospholipid Binding Affinities of RS Variants.
The equilibrium partitioning of RS between phospholipid-bound
and free populations has been investigated for the wild-type
protein and each of the disease variants upon addition of small
unilamellar vesicles (SUVs). All vesicles used inour studyconsist
of a 5:3:2 DOPE:DOPS:DOPC molar ratio, maintaining a net
negative charge and lipid moieties native to the synapticenviron-
ment (45). The size and curvature of our model SUVs approxi-
mate those of synaptic vesicles. These vesicles are added to a
solutionofRS,andtheirimpactuponthetwo-dimensionalNMR864 Biochemistry, Vol. 49, No. 5, 2010 Bodner et al.
spectrum is monitored in a residue-specific manner (Figure 1A,
shown for a small section of the two-dimensional
1H-
15N
correlation spectrum of E46K RS). The fractional attenuation
of signal intensity for any given backbone amide
1H-
15N cross-
peak in the heteronuclear single-quantum correlation (HSQC)
spectrum indicates that a corresponding fraction of the RS
population is engaged in phospholipid binding in a mode in
which the amide group of this residue exhibits line widths too
broad to be observed in the HSQC spectrum (39). The retained
signal intensityarises both from RS moleculesthatarefully lipid-
free and from RS residues that are themselves free and dynami-
cally disordered, even while an “upstream” (more N-terminal)
segment of the same protein molecule is lipid-bound with its
NMRsignalsunobservable.Inbothcases,theobservedchemical
shifts are identical to those observed for RS in the absence of
lipids because they arise from RS residues in the dynamically
highly disordered state.
Whenthesignalattenuationinthe
1H-
15NHSQCspectrumis
viewedasafunctionofresiduenumber(Figure1B),thespectrum
is dramatically impacted by the presence of lipids, both for WT
RS and for the three disease mutants, even at very low lipid:
protein molar ratios (near unity). This result is reminiscent of the
signal attenuation previously noted for aS in the presence of
equimolar quantities of various fatty acids (9). As observed for
WT RS( 39), each of the disease variants shows a differential
degree of binding across its sequence, with the N-terminal
residues (segments containing ca. the first 10, or the first 24,
amino acids are distinguished in particular) partitioning most
strongly into the NMR-invisible lipid-bound state. We term this
firstboundstate,comprisedofashortboundR-helixfollowedby
dynamic disorder in residues ∼25-140, SL1. A second bound
state,whichwetermSL2,engagesthefullN-terminaldomain,up
to residue ∼100, in the R-helical conformation, while the 40
residuesoftheC-terminaltailremainflexibleinsolution.Akinto
the wild-type scenario, each of the RS variants binds to SUVs
with exchange kinetics that are slow on the NMR time scale,
evidenced by the lack of significant broadening or shifting of any
oftheHSQCresonances,evenwhiletheintensitiesareattenuated
due tolipid binding. Thekinetics areinvestigated indetailbelow,
but we point out here that the modes of binding are very similar
to those previously described for WT RS( 39).
Toensurethat the binding modesobservedfor the RS variants
are not the result of altered vesicle morphology induced by the
mutant proteins, two additional experiments were conducted. In
the first, we tested whether large unilamellar vesicles (LUVs) of
the same composition as our SUVs alter the lipid binding profile
of RS (Figure 2 of the Supporting Information). For the first 100
residues, the attenuation pattern is essentially the same between
the two vesicle sizes, indicating that the binding modes are
insensitive to the initial vesicle diameter. In a second set of
experiments, the attenuation of the signal for mixed samples of
WT and A30P RS was monitored (Figure 3 of the Supporting
Information). Equimolar amounts of isotopically labeled WT
and unlabeled A30P RS, or the reverse labeling scheme, were
added to the lipid vesicles. As expected, WT and A30P RS
compete (with A30P having a lower affinity) for lipid binding
sites, affecting the degree of attenuation observed for each
protein. However, the patterns of attenuation for WT and
A30P RS remain unchanged in the presence of the other protein.
While the lipid morphology may be disrupted by the presence of
RS [as observed by cryo-electron microscopy on samples of RS
added to the same SUVs (39)], results obtained for the mixed
samples indicate that alterations in lipid morphology are not
responsible for the different modes of binding observed for each
of the RS variants.
The lipid binding affinity of the first 10 N-terminal residues of
A30P RS approaches that of the wild-type protein. A segment
containing residues 11-23 exhibits progressively increasing
resonance intensity, corresponding to an increasing fraction of
the disordered population, and the attenuation shows a flat
profile at∼75% intensity relative tothe lipid-free state beginning
from around residue 25, a point just preceding the mutation site.
This indicates that for a fraction (∼25%) of A30P RSr e s i d u e s
25-100 are in a lipid-bound state, whereas for the remaining
75% of the protein, this part of the chain is fully disordered, in a
random coil-like state. The weaker binding compared to that of
WTforthemajorityoftheN-terminalresiduesisexpectedonthe
basis of the decreased helix propensity of the A30P variant, as
WT binds lipids in an R-helical mode. Proline is known to
disfavor R-helix formation both because it has no amide proton
that can engage in hydrogen bonding and because its cyclic side
chainlocksthejbackbonetorsionangleatapproximately-75.
While the overallbound populationofA30P RS isonlymodestly
reduced (54% bound) relative to the wild-type population (63%
bound), the redistribution of bound modes is more striking:
FIGURE 1: Signal attenuation observed in the
1H-
15NH S Q Cs p e c -
trumofRScorrespondstothefractionalpopulationofRSengagedin
phospholipid binding at a particular residue location. (A) Cross
section of the
1H-
15N HSQC spectrum of E46K RS, in the absence
(black) and presence (red) of 0.03% SUVs. (B) Fractional signal
attenuationofwild-type(black),A30P(blue),E46K(gold),andA53T
(red) RS in the presence of 0.03% (w/v) SUVs plotted as function of
residue number. The protein concentration for all series is 300 μM,
such that the lipid to protein molar ratio is approximately 4:3.Article Biochemistry, Vol. 49, No. 5, 2010 865
inspectionofthecurves for WT andA30PRS (Figure 1B) reveals
thattheratioofSL1toSL2bindingmodesisgreatlyincreasedby
the mutation.
In reality, the designation of SL1 and SL2 is a simplified
classification comprising a number of different modes evident in
the intensity profiles, each the result of a discrete set of contig-
uous, bound residues (always beginning at the N-terminus).
Inspection of the A30P and E46K data series in particular shows
a number of clear “steps” in the attenuation profile (Figure 1B).
Even though such steps are not as pronounced for the WT and
A53T series at low lipid concentrations, they are readily seen at
higher lipid levels (Figure 2). These intermediate-bound modes,
terminating between residues 25 and 100, constitute distinct
modes of RS that are differentially populated by WT RSa n d
each of the disease mutants. Considering that none of the
resonances shows line broadening or resonance shifting relative
to lipid-free RS, each of these modes is separated by an energy
barriersufficientlylarge togive risetothe slow kineticsobserved.
In practice, accurate measurement of these modes is limited by
the signal-to-noise ratio of the experiment and some instances of
signal overlap in the HSQC spectrum, which becomes progres-
sivelymoreproblematicforstronglyattenuatedresonancesinthe
vicinityofmuchlessattenuatedsignalsfromresiduesclosertothe
carboxy terminus. For this reason, the following analysis is
focusedonthesimplifieddepictionofSL1,SL2,andtheirrelative
population ratios. The total population of bound RS( u n d e r
any mode) corresponds to the fractional attenuation of the most
N-terminal segment and is compared for WT RS and each of the
disease variants in Table 1. The fraction of RS bound as SL2 has
been determined as the average fractional attenuation for
residues65-80,wheretheattenuationprofilesinFigure1Bshow
remarkable consistency. The fraction of RS bound as SL1 was
calculated by subtracting the SL2 fraction from the average
fractionalattenuationobservedforresidues3-9(i.e.,yieldingthe
population that is bound at the N-terminus but not bound at
positions 65-80).
The E46K RS variant displays an overall higher level of lipid
partitioning of SL1, SL2, and all intermediate modes, relative to
that of the wild type. This result is readily understood from the
viewpoint of electrostatics, since a negative glutamate is replaced
with a positive lysine, favoring interactions with the SUV lipid
mixture which carries a net negative charge. The mutation raises
the net charge of the 100-residue N-terminal domain from þ4t o
þ6. Though quantification of the simplified SL1:SL2 ratio in the
E46K mutant appears to be essentially the same as for WT, the
increased affinity nevertheless increases the population of SL1
by ∼25%.
Among the three disease variants, the A53T mutation has the
most subtle effect upon lipid binding. The attenuation profile
(Figure 1B) is only slightly offset from the WT curve, correlating
to a modest elevation of the SL1 binding mode, even while the
overall binding affinity (absolute fraction bound under any
mode) appears similar to that of the wild type. To a lesser degree
thanfortheA30Pmutation,A53Talsoexhibitsanincreaseinthe
ratio of SL1- to SL2-bound populations.
The results above describe the lipid-limited case, where the
different bound modes are in competition for phospholipid
targets. The bound populations of RS have also been quantified
atan intermediatelipidconcentration (lipid:RSr a t i oo f∼11) and
under excess lipid conditions (lipid:RSr a t i oo f∼86). As before,
the attenuation of the signal in the HSQC spectrum is used as a
reporter of binding in a site-specific manner (Figure 2). Particu-
larly at the highest lipid concentrations, these measurements are
made more difficult because the signal-to-noise ratio suffers for
the highly attenuated resonances. Additionally, the intensity
ratios determined for resonances of the C-terminal tail become
less consistent as these peaks show small heterogeneities in their
shifts under these high-lipid conditions, manifesting themselves
as multiple small distinct shoulders or very proximate weaker
resonances (data not shown). These chemical shift heterogene-
ities result in some scatter of the intensities measured for this
region. Nevertheless, these attenuation patterns show the excess
lipid condition to be a continuous extension of the lipid-limited
case and allow us to compare trends between the RS variants.
At a weight by volume lipid concentration of 2.0% (lipid:
protein molar ratio of 86), reliable intensities for the ∼20
FIGURE 2: Effect of increased lipid concentrations on the binding of
RSanditsdiseasevariants.FractionalintensityintheHSQCisshown
for WT(black), A30P (blue), E46K(gold), and A53T (red) RSi nt h e
presenceof0.25(A)or2.0%SUVs(B).Thelipid:proteinratiois11:1
or 86:1, respectively. N-Terminal residues whose intensities are too
weak for reliable detection have been omitted. For C-terminal
residues, which show slightly heterogeneous chemical shifts in the
2.0% SUV condition (see the text), fractional intensities plotted in
panel B reflect the attenuation of the nonshifted resonance.
Table 1: Disease Variant Equilibrium Populations under Dilute Lipid
Conditions
a
total bound
population
a
SL1 fractional
population
b
SL2 fractional
population
c
ratio
(SL1:SL2)
WT RS 0.63 0.21 0.43 0.49
A30P RS 0.54 0.30 0.25 1.2
E46K RS 0.81 0.26 0.53 0.49
A53T RS 0.58 0.24 0.33 0.73
aDerived from attenuation data of Figure 1B.
bDifference between
fractional attenuation of residues 3-9 and average fractional attenuation
of residues 65-80.
cAverage fractional attenuation for residues 65-80.866 Biochemistry, Vol. 49, No. 5, 2010 Bodner et al.
N-terminal residues can no longer be detected for any of the
variants. Stronger lipid partitioning of E46K RS persists even
with the lipid limiting condition removed, as residues up to
position53areunobservedforthisvariant(Figure2B).ForA30P
RS, deficient binding of residues 24-36 persists at the intermedi-
ate lipid concentration (Figure 2A) and at the highest lipid
concentration, curiously, shows a higher free fraction for this
segment than residues located adjacently in the C-terminal
direction. This suggests that the helix-perturbing mutation also
can result in a high level of local dynamic disorder for these
residues, even while the remainder of the N-terminal domain
remains tightly bound. The fact that these resonances are
observed and exhibit random coil-type line widths is further
evidence of the “jointed” lipid binding of RS, which displays
sharpboundariesbetweenorderedandhighlyflexibleresidues.In
spite of these observations, other binding features that differ-
entiate the RS variants at low lipid concentrations are largely
absent at the higher lipid concentrations investigated. In parti-
cular, no appreciable free population persists for any of the
variants in excess lipids. If the factors that dispose RSt o w a r d
disease are linked to its capacity to bind lipids, it is likely that
deficits would be most acute under competitive binding condi-
tions, as observed in Figure 1.
Kinetics of Binding Are Affected by RS Mutations. The
altered steady state bound populations of RS disease variants
could be due to changes in the lipid association rate, dissociation
rate, or both. As shown previously for WT RS( 39), the lipid
association rate can be conveniently probed as a contribution to
the decay of signal in a TROSY-HSQC experiment when
monitoring the
15N transverse magnetization decay rate R2
T.
Such a measurement is only possible when the free-bound
forward transition occurs on a time scale not much slower than
the inverse of the intrinsic transverse relaxation rate of the
random coil state and is a remarkable feature of the long-lived
exchangeable states of RS and the slow transverse relaxation of
dynamically disordered RS. An analogous set of transverse
relaxation data was acquired for each of the disease variants.
Inthe slow-exchange limit,the observed R2
T equalsthe sum of
the R2
T value of the highly mobile lipid-free random coil state,
R2
T
random_coil,andtheforwardrateofthefree-boundtransition,
kon. R2
T values in the lipid-free state for RS are very low, ∼3s
-1
(Figure 3), allowing straightforward detection of even relatively
small contributions resulting from kon. With the exception of
several residues for which the intrinsic random coil hydrogen-
exchange rate is highest (46) and for which this type of exchange
impacts the apparentR2
T value, transverse relaxationrates inthe
absence of lipid are quite uniform and very low, in agreement
with a highly mobile, disordered random coil-like conforma-
tion(33,47-49).Inthepresenceoflipids,asignificantincreasein
the transverse decay rate is observed for residues 1-100
(Figure 3), indicative of kon values in the range of 3-6s
-1.
The rates measured for the 40 residues of the C-terminal tail
are highly uniform, corresponding to T2 values of ∼350 ms,
regardless of the presence of lipids or any of the three point
mutations. As expected, the presence of dilute lipids (lipid:RS
molar ratio of ∼1.3) elevates the effective R2
T measured for the
N-terminal domain for WT and all variants of RS. Comparison
of the rates measured for WT, E46K, and A53T RSr e v e a l s
minimal differences between the data series, signifying nearly
identicalassociationratesforthesevariants(plotsnotshown,but
rates summarized in Table 2). In the case of E46K RS, for which
the equilibrium constant is increased (i.e., the bound fraction is
increased), this unaltered association rate specifies that the lipid
dissociation rate must be slower than that of the wild type. In
contrast, the A30P mutation results in lower R2
T values relative
to that of WT RS under identical lipid conditions (Figure 3).
Taking the difference between the effective R2
T and the intrinsic
transverse relaxation rate measured for RS in the absence of
lipids, we obtain the lipid association rate, kon, for both WT and
A30P RS in a site-specific manner. Across the N-terminal region,
a2 -3-fold reduction in the kon rate is observed for A30P relative
to WT RS. With the equilibrium-bound fraction also known
(Figure 1B), the dissociation rate is derived.
The average rates and equilibrium populations of each of the
RS variants are reported for a stretch of residues near the N-
terminus, V26-T33, inclusive. Located in the beginning of the
“SL2” region, this set of representative residues is approximately
flat in their attenuation profiles and also exhibits relatively
consistent R2
T values. In the A30P construct, the association
rate for this region is decreased, as mentioned above, but the
calculated dissociation rate is insensitive to the mutation. The
lowered binding affinity then must be attributed entirely to a
slower kon. An opposite effect on kinetics is observed for the
E46K variant. Here, the mutation affects the dissociation rate,
koff (slowing it by a factor of >2), while kon is only modestly
modified from the wild-type rate. Further discussion of the
possible sources of altered kinetics is presented later.
NOE Transfer in the “Dark State”. Previously, H
N-H
N
NOE correlations of the dark state of RS were measured via 3D
NOESY experiments (39). Analogously, 3D HMQC-NOE-
HMQC spectra were acquired for each of the disease variants
in the presence of 0.06% lipid (lipid:protein molar ratio of ∼1.3).
Because NOE experiments store magnetization along the longi-
tudinal axis, protein molecules that associate as a bound
complex and dissociate within the NOE mixing time of the
experimentretainthe “memory” oftheirbound stateand display
FIGURE 3: Transverse relaxation rates of the
15N TROSY compo-
nent, R2
T, measured for 600 μMW TRS (white circles) or A30P RS
(graycircles) inthe presenceof0.06% SUVs. The rates measuredfor
WT RS in the absence of lipids are also plotted (black circles).
Table 2: Lipid Association and Dissociation Rates for RS Variants
a
bound fraction experimental kon (s
-1) calculated koff (s
-1)
WT RS 0.60(0.01 6.1(0.6 4.1( 0.4
A30P RS 0.28( 0.02 1.9(0.5 4.8(1.4
E46K RS 0.75(0.01 5.7(0.6 1.9(0.2
A53T RS 0.51(0.03 5.7(0.8 5.5(0.8
aReported as the average values for residues 26-33 under the low-lipid
conditions described in the legend of Figure 3.Article Biochemistry, Vol. 49, No. 5, 2010 867
cross-peaksthatreportonNOEmagnetizationtransferthattook
place during that time. As found for the 40 C-terminal residues,
and previously observed for WT RSi nt h ea b s e n c eo fl i p i d s( 39),
NOE magnetization transfer for the disordered, random coil
state of RS is very slow, contributing minimally to cross-peaks
between the amide protons. NOE cross-peaks observed for the
100 N-terminal residues in the presence of lipids therefore are
dominated by the structure and dynamics in the lipid-bound
state.
In comparison to lipid-bound WT RS, which displays numer-
ous i to i ( n connectivities (up to n = 6) due to extensive spin
diffusion in the dark state (39), the NOE cross-peak pattern in
A30P RS is sharply reduced. Throughout the SL2 region, cross-
peak intensity ratios, relative to the diagonal peak of a given
residue, are approximately2-fold weaker thanthe corresponding
cross-peaks of WT RS under the same conditions (data not
shown). This result agrees well with the attenuation data of
Figure 1B which shows nearly twice the SL2 population for WT
versusA30PRSandsimplyreflectsthelowersignal-to-noiseratio
for cross-peaks arising from a reduced bound population in the
mutant. However, in the N-terminal segment preceding position
30,thepatternofcross-peaksobservedisadditionallyaffectedby
the mutation. Figure 4 shows a number of strips taken from the
3D HMQC-NOE-HMQC spectrum for residues G25-L38 of
theA30Pvariant.IncontrasttowhatwaspreviouslyseenforWT
RS,inthevicinity of the mutationsite, the monotonic decrease in
cross-peak intensities for increasing n is not observed in all cases.
Instead, i-i ( 3 cross-peaks show higher intensities than i-i ( 1
and i-i ( 2 cross-peaks in some instances [for example, see the
mirrored cross-peaks between V26 and A29 that are approxi-
mately 6 times more intense than those between V26 and A27
(Figure 4)]. Although quantitative interpretation of cross-peak
intensities in terms of interproton distances is complicated by the
unknowndegreeofspindiffusion,thisfindingstronglysuggestsa
V26 H
N-A29 H
N distance that is comparable to the distance of
2.8 A ˚ between sequential amide protons in an R-helix, and a
considerably longer sequential V26 H
N-A27 H
N distance. Short
distances between amide protons of residues i and i þ 3a r e
characteristic of turn-type conformations but without additional
structural information are insufficient for the determination of
the specific turn type.
E46K RS also shows significant variation from WT in its
H
N-H
N NOE cross-peak pattern. The overall number of cross
peaks detected is again reduced for the E46K mutant (Figure 5)
relative to WT RS. However, in contrast to the A30P mutant,
attenuationof intensities is comparable towhat isseen inWT RS
and therefore cannot be attributed to a lower population of dark
state RS. Instead, the lower NOE cross-peak intensity is caused
by its slower koff rate relative to that of WT RS (Table 2), which
causes fewer molecules to undergo a transition from free to
FIGURE 4: Series of strip plots showing
1H-
1H amide NOEs for residues 25-38 (excepting P30) of 600 μMA 3 0 PRS in the presence of
0.06%SUVs.Stripsare taken orthogonaltothe
1H frequency axisofa600 MHz 3DHMQC-NOESY-HMQC spectrum.The NOEmixingtime
was 100 ms.868 Biochemistry, Vol. 49, No. 5, 2010 Bodner et al.
bound to free in the 100 ms NOE mixing time of the experiment.
This effect is partially offset by the increased level of binding of
the E46K variant, but nevertheless, cross-peaks are somewhat
weaker for this mutant relative to WT and also relative to the
A53T variant (Figure 1 of the Supporting Information). Intrigu-
ingly, monotonic decay of cross-peaks with an increasing
n appears to be suspended for the region from G25 to A29 in
the spectrum of E46K RS: the i þ 4 cross-peak in the G25 strip
appears twice as intense as the i þ 3 cross-peak. As in the A30P
mutant, this suggests that this region may engage in motifs other
than the canonical helix observed for the rest of the N-terminal
domain. However, the clear signature of extensive spin diffusion
along the protein backbone prevents more quantitative inter-
pretation of the NOE data.
H
N-H
N NOE transfer in A53T RSi so b s e r v e dw i t ha n
intensity pattern very similar to that of WT, without evidence
of helical breaks either in the region of residues 25-30 or in the
vicinity of the mutation site (Figure 1 of the Supporting
Information).
DISCUSSION
In addition to their value in yielding potential insights into the
molecular mechanisms of Parkinson’s disease pathology, com-
parison studies of the RS disease variants also highlight impor-
tantbiophysicalaspectsofthenativelipidinteractionsofRS.The
intensity and relaxation data reported here reveal how the
mutation sites of RS affect its behavior both locally and globally.
Studies that have employed circular dichroism, isothermal titra-
tion calorimetry, or other methods that lack site-specific resolu-
tionhavebeenlimitedtomakingmoregeneralconclusionsabout
the global affinity of RS and its variants for lipid vesicles.
Fluorescence and EPR studies have been able to report on a
numberofspecificallylabeledsiteswithinRS(50-56),butsingle-
or double-site labeling is both cumbersome and potentially
perturbing to the native binding. The finer lens of solution
NMR is ideal for examining the differential effects of the
disease-associated mutations on RS-lipid binding. A prior
NMR study of binding of RS and two of its mutants, A30P
and A53T, to lipid vesicles of various compositions observed
spectral intensities in terms of average lipid binding capacity of
the protein’s ∼100 N-terminal residues, and its 40-residue acidic
C-terminal tail (35, 57). When using this coarse distinction, the
results presented herefully agree withthe earlier conclusionsthat
on average the lipid binding propensity of the 100 N-terminal
residues is higher than for the C-terminal tail, with little impact
fromthediseasemutations.However,whenanalyzingthedatain
the site-specific manner employed in this study, we see consider-
able differences. For example, we find that the 12 N-terminal
residuesoftheA30Pmutantretainhighlipidbindingaffinityand
that the N-terminal domain region following the mutation site
FIGURE 5: Series of strip plots showing
1H-
1H amide NOEs for residues 25-38 of 600 μME 4 6 KRS in the presence of 0.06% SUVs. Strips are
taken orthogonal to the
1H frequency axis of a 600 MHz 3D HMQC-NOESY-HMQC spectrum. The NOE mixing time was 100 ms.Article Biochemistry, Vol. 49, No. 5, 2010 869
(residues G31-L100) binds in an “all-or-nothing” fashion,
yielding a very flat attenuation pattern for this region, whereas
for WT and the other disease variants, the level of attenuation
decreases when moving in the C-terminal direction. The latter
points to distinctly different stable binding modes, which termi-
nate at different locations in the G31-L100 segment. For the 40
C-terminal residues, no lipid binding is observed at low lipid:RS
ratios, but as previously observed for WT, considerable reso-
nance attenuation is seen at high ratios, with distinct steps at
locations that coincide with the positions of proline residues
(at P120 and P128). No large differences between the lipid
binding characteristics of WT and the three mutants are seen
at high lipid:protein ratios, however.
Forces Driving the Binding Kinetics of the RS-Lipid
Particle. The opposite effects on the kinetics of lipid binding
induced by the A30P and E46K mutations shed light on the
forcesdriving the RS-lipidinteraction.Thelipidassociation rate
is sensitive to the helical propensity of RS (which is impaired by
the A30P mutation), while the dissociation rate is more sensitive
to electrostatic interactions (which are promoted by the E46K
mutation). Binding can be viewed as a two-step process of
encounter and reaction. In the case of binding of RSt ol i p i d ,
the overall observed rate appears to be governed by the reaction
afterencounter withlipids, since the A30P mutationcan slowthe
association rate. This inhibition of kon is likely caused by the
inability of free A30P RS to transiently adopt an ideal R-helical
conformation encompassing the mutation site. Formation of the
R-helical secondary structure alone, however, is insufficient to
provide the driving force for the association of the RS-lipid
particle since there is little free energy difference between back-
bone residues forming intramolecular hydrogen bonds to stabi-
lize the RS helix and the same backbone residues forming
hydrogen bonds to solvent molecules, resulting in the modest
R-helical propensity observed for RSi nf r e es o l u t i o n( 33). Con-
sequently, the interaction of hydrophobic side chains of the N-
terminal domain of RS with the hydrocarbon tails of the lipids is
thelikelydrivingforceofassociation.Loweringthepopulationof
a helical “transition state” which exposes its hydrophobic side
chains in a pattern ready for lipid association will therefore slow
the lipid binding rate. Once RSisboundtothenegativelycharged
lipids, however, electrostatic interactions dominate the stability
of the particle. The favorable changes in electrostatics in the
E46K variant when bound to negatively charged lipids slow the
dissociation of RS from the particle. Since charge-charge
attraction or repulsion is effective only over relatively short
distances (the Debye length is approximately 12 A ˚ for aqueous
samples at low salt concentrations), the dissociation rate is more
likely to be impacted by electrostatics than the encounter rate
between the helical state of RS and lipids.
The low lipid:protein stoichiometry (approximately 2:1) of the
bound complex necessarily results in a highly charged bound
complex.The 100 N-terminalresiduesofRS carrya netchargeof
þ4, while 30% of the lipids in the DOPE/DOPS/DOPC SUVs
are negatively charged. Although the lipid composition of the
RS-lipid particles is not precisely known, even if the RS-binding
lipids were restricted to the negatively charged DOPS compo-
nent, the core of the resulting particle carries a substantial
positive charge. For higher-order oligomers, the particle likely
cannot be sustained without substantial charge compensation.
Attenuation of the C-terminal residues at higher lipid concentra-
tions (see, e.g., Figure 2) indicates an interaction of this tail for a
fraction of the proteins in the particle and may reflect the
association of the negatively charged tail (net charge of -13)
with the bound complex as a means of neutralizing the positive
core. Indeed, the C-terminal residues of the E46K variant show
more attenuation than those of WT or other RS variants under
dilute lipid conditions (Figure 1B). A recent study also notes an
increased number of C-terminal to N-terminal contacts in the
absenceof lipids for the E46K mutant,asdeterminedbysolution
NMRparamagneticrelaxationenhancementmeasurements(34).
Possible Mechanism for the Potency of A30P, E46K,
and A53T Mutations. Under lipid-limited conditions, parti-
tioning of the distinct phospholipid binding modes of RSi s
affected by each of the three known disease mutations. The
higher, comparable, and lower total lipid affinities of E46K,
A53T, and A30P RS variants have, to this point, been difficult to
understand with respect to PD etiology. This paradox, however,
appearstobelargelyresolvedwhenconsideringtherelativeratios
of the different lipid-bound states of RS, in addition to global
binding. For each of the disease variants, a redistribution of
bound modes, relative to wild-type RS, is observed.
The absolute fraction of RS bound as SL1 is significantly
increased by the E46K mutation, while the relative abundance of
binding modes SL1 and SL2 is increased by the A30P and A53T
mutations (Table 1). In the case of A30P RS, the SL1 binding
mode even outnumbers the SL2 binding mode at low lipid
concentrations, which represents an inversion from the wild-type
populations. Although we are unable to directly measure the
SL1 concentration in its relevant cellular environment, our data
strongly suggest it to be impacted by the SL1:SL2 ratio.
Figure 6 schematically illustrates how the SL1 binding mode,
which anchors the N-terminus of RS in the lipoprotein complex
while the more hydrophobic NAC region remains disordered, is
prone to intermolecular interactions which may progress toward
disease-associated oligomers and fibrils. We propose that the
increase in SL1 levels, associated with the perturbation of the
SL1:SL2 distribution, may contribute to the increased toxicity of
theA30PandA53TdiseasevariantsofRS,whereasfortheE46K
variant, it is the higher membrane affinity that increases the SL1
concentration.
It has been previously documented that low lipid or detergent
concentrations promote fibrilization of RS( 1-4, 6, 58), citing as
cause the increased local concentration of RSw h e nm a n y
molecules compete for binding to a limited surface area. Indeed,
FIGURE 6: Schematic depicting the proposed increased vulnerability
of RS to self-association when engaged in the SL1 binding mode vs
SL2.TheA30PandA53Tdiseasemutationsbothincreasetherelative
population of SL1, for which a long unstructured stretch of
N-terminal residues (including the hydrophobic NAC region) is
exposed.870 Biochemistry, Vol. 49, No. 5, 2010 Bodner et al.
the duplication ortriplication ofthe SNCAgene that encodes RS
synuclein has also been correlated with genetic PD. The scheme
proposedhereextendsthisargumentbyhighlightingthefactthat
lipid-limited conditions additionally promote a more aggrega-
tion-prone lipid binding mode of RS (SL1), while decreasing the
level of conformations that may naturally work to offset aggre-
gation propensity (SL2 or intermediate modes). Next to the
increase in the relative concentration of fibril formation-prone
SL1, it is important to note that the SL1 binding mode arranges
the NAC region of these proteins (59, 60) in a roughly parallel
arrangement, promoting the formation of parallel β-sheet sec-
ondary structure observed for this region in amyloid fibrils (61).
Therefore,whenthemoleculesarelinedupin-register,theriskfor
aggregation is particularly increased. The E46K variant, which
overpopulates this binding mode, and the A30P and A53T
variants, which elevate the SL1:SL2 ratio of binding modes
relative to that of WT RS, all exhibit increased potential for this
fibril-prone condition.
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